ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
SAN DIEGO, January 3, 2024 – ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial
and operational results for the second quarter of fiscal year 2024 on Wednesday, January 24, 2024, after the New
York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the
results. Other forward-looking and material information may also be discussed during the webcast.
Buy RMD now and get great upside returns in a year or two, page-96
-
- There are more pages in this discussion • 102 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$31.27 |
Change
-0.050(0.16%) |
Mkt cap ! $19.81B | |||
| Open | High | Low | Value | Volume |
| $31.70 | $31.84 | $31.09 | $82.98M | 2.646M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22500 | $31.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $31.31 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| RMD (ASX) Chart |